Take melanoma as another model where BRAFV600E-induced BRAF/MAPK activation is also the most dramatic carcinogenic mutation, we found knock-down of USP15 resulted in significant TBX3 reduction (Supplementary Fig. 4c). This evidence concerns the gene TBX3 and melanoma.